|Title:||Acid addition salts of hydropyridine derivatives|
|Abstract:||Acid addition salts of 2-acetoxy-5-(.alpha.-cyclopropyl-carbonyl-2-fluorobenzyl)-4,5,6,7-tetrahyd rothieno[3,2-c]-pyridine. The acid addition salts of tetrahydrothienopyridine derivatives of the present invention exhibit excellent oral absorption, metabolization into the active compound, and platelet aggregation-inhibiting effects, low toxicity, and excellent storage and handling stabilities, and are useful as medicaments, preferably preventive or therapeutic agents (particularly therapeutic agents) for diseases caused by a thrombus or an embolus, still more preferably preventive or therapeutic agents (particularly therapeutic agents) for thrombosis or embolism.|
|Inventor(s):||Asai; Fumitoshi (Tanashi, JP), Ogawa; Taketoshi (Tokyo, JP), Naganuma; Hideo (Tokyo, JP), Yamamura; Naotoshi (Nishitokyo, JP), Inoue; Teruhiko (Ube, JP), Nakamura; Kazuyoshi (Onoda, JP)|
|Assignee:||Sankyo Company, Limited (Tokyo, JP) Ube Industries Ltd. (Ube, JP)|
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Use;|
Back Citations: 7th percentile
Forward Citations: 0th percentile
|Patent Number||Expiration Date|
|6,693,115||February 17, 2016|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.